Linda Rosencrance is a freelance writer/editor/author in the Boston area. Rosencrance has over 30 years experience as an investigative reporter, writing for many newspapers in… Artificial intelligence ...

The American Diabetes Association (ADA) recently released their 2025 Standards of Care, which – for the first time – includes recommendations for CGM use in type 2 diabetes, the use of GLP-1 drugs for ...

Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. NEW ORLEANS — A senior ...